Ken Griffin Inovio Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.79 - $1.91 $600,613 - $1.45 Million	760,270 Added 377.79%	961,513 $788,000
Q4 2022 Feb 14, 2023	SELL	$1.41 - $2.5 $1.16 Million - $2.06 Million	-825,966 Reduced 80.41%	201,243 $313,000
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $1.14 Million - $1.91 Million	685,221 Added 200.36%	1,027,209 $1.77 Million
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $268,449 - $741,963	186,423 Added 119.84%	341,988 $592,000
Q1 2022 May 16, 2022	SELL	$2.97 - $5.2 $2.18 Million - $3.81 Million	-733,522 Reduced 82.5%	155,565 $558,000
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $2.11 Million - $3.15 Million	422,325 Added 90.48%	889,087 $4.44 Million
Q3 2021 Nov 15, 2021	SELL	$7.16 - $9.69 $3.55 Million - $4.8 Million	-495,223 Reduced 51.48%	466,762 $3.34 Million
Q2 2021 Aug 16, 2021	SELL	$6.23 - $10.03 $240,409 - $387,047	-38,589 Reduced 3.86%	961,985 $8.92 Million
Q1 2021 May 17, 2021	BUY	$8.81 - $16.96 $2.55 Million - $4.91 Million	289,318 Added 40.68%	1,000,574 $9.29 Million
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $2.59 Million - $3.91 Million	304,196 Added 74.73%	711,256 $6.3 Million
Q3 2020 Nov 16, 2020	BUY	$9.57 - $27.05 $3.57 Million - $10.1 Million	373,004 Added 1095.27%	407,060 $4.72 Million
Q2 2019 Aug 14, 2019	SELL	$2.29 - $4.1 $38,226 - $68,441	-16,693 Reduced 32.89%	34,056 $100,000
Q1 2019 May 15, 2019	SELL	$3.34 - $5.1 $18,693 - $28,544	-5,597 Reduced 9.93%	50,749 $0
Q4 2018 Feb 14, 2019	SELL	$3.89 - $6.11 $115,089 - $180,770	-29,586 Reduced 34.43%	56,346 $225,000
Q3 2018 Nov 13, 2018	SELL	$3.92 - $5.58 $1.49 Million - $2.12 Million	-379,687 Reduced 81.54%	85,932 $0
Q2 2018 Aug 10, 2018	BUY	$3.88 - $5.16 $56,682 - $75,382	14,609 Added 3.24%	465,619 $0
Q1 2018 May 11, 2018	SELL	$4.05 - $5.69 $1.03 Million - $1.45 Million	-255,509 Reduced 36.16%	451,010 $2.12 Million
Q4 2017 Feb 09, 2018	BUY	$4.13 - $6.68 $472,823 - $764,759	114,485 Added 19.34%	706,519 $2.92 Million
Q3 2017 Nov 09, 2017	BUY	$5.36 - $6.37 $3.17 Million - $3.77 Million	592,034	592,034 $3.75 Million

Others Institutions Holding INO

# of Institutions

Shares Held

281K

Call Options Held

Put Options Held

View Full List

About INOVIO PHARMACEUTICALS, INC.

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

More about INO

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account